EPO Enlarged Board to consider principles of claim interpretation

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EPO Enlarged Board to consider principles of claim interpretation

Sponsored by

inspicos-400px recrop.jpg
advertisement-2098989.jpg

Jakob Pade Frederiksen of Inspicos reviews a recent referral to the EPO Enlarged of Board of Appeal relating to the impact of statements in the description on the interpretation of claims

On April 10 2024, a technical board of appeal of the EPO decided at oral proceedings in relation to case T 439/22 (opposition proceedings against European patent 3 076 804) to refer a fundamental question of law to the Enlarged Board of Appeal (EBA). The issue to be considered by the EBA relates to claim construction, particularly with regard to the significance of statements in the description on the interpretation of claims.

The patent-in-suit relates to a heated aerosol-generating article comprising an aerosol-forming substrate, such as a tobacco substrate. The aim of such aerosol-generating articles is to reduce harmful smoke constituents produced in conventional cigarettes. Claim 1 of the patent recites “a gathered sheet of aerosol-forming material”. According to the description of the patent, the term “gathered” has a broad meaning.

While the written decision of the technical board of appeal has not yet become available at the time of writing, the preliminary opinion of the board, issued on December 5 2023, indicates that a particular piece of prior art potentially deprives the subject matter of claim 1 of novelty if the feature “gathered sheet” is interpreted according to the broad definition indicated in the description. However, the subject matter of claim 1 might be considered novel if the term “gathered sheet” is interpreted more narrowly in accordance with a skilled person’s ordinary understanding of the term.

As noted by the board in the preliminary opinion, according to one line of case law (e.g., T 1473/19), the broad definition given in the description of the patent cannot be left unconsidered, whereas, according to another line of case law (e.g., T 169/20), the description should only be resorted to for interpreting the claims in the exceptional case where clarification is required; i.e., when a skilled person does not have a firm understanding of what a particular feature means in the relevant field of art.

According to the preliminary opinion of the technical board of appeal, a narrow interpretation of the claim language ignoring a definition given in the description would potentially conflict with a broader interpretation by national courts of the Unified Patent Court in infringement proceedings.

more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article